Acrivon adds immunology pillar, reports Q3 2026 results and ACR-2316 data aheadNov 16Quarterly updateACR-2316Acrivon Therapeutics
Acrivon reports Q2 2026 results, flags ACR-368 interim data for second half of 2026Aug 12Quarterly updateACR-2316Acrivon Therapeutics